Results: The 5 - year overall and progression - free survival rates for 100 % and % , respectively.

结果: 五年的整体存活率及无疾病进展存活率分别为100%及%.

互联网

Progression free survival and response rates did not differ significantly among the regimens.

不同方案之间无进展生存率和有效率无显著性差异.

互联网

Results: The 5 - year overall and progression - free survival rates for all patients were 100 % and 92 % , respectively.

结果: 五年的整体存活率及无疾病进展存活率分别为100%及92%.

互联网

Results: The 5 - year overall and progression - free survival rates for % and 92 % , respectively.

结果: 五年的整体存活率及无疾病进展存活率分别为%及92%.

互联网